Network Point-of-Care Glucose Testing Market Size is Predicted to Witness 3.9% CAGR till 2028

[sara James]

The global Network Point-Of-Care Glucose Testing Market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

List of Key Players of Network Point-of-Care Glucose Testing Market

• F. Hoffmann-La Roche Ltd.
• Abbott
• Nova Biomedical
• Bayer AG/Ascensia Diabetes Care Holdings AG
• Danaher

Related Reports@ Network Point-of-Care Glucose Testing Market Report

Network Point-of-Care Glucose Testing Market Report Highlights

• Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring
• Based on product, the Accu-Chek Inform II segment held the largest revenue share in 2020 and is expected to expand at a lucrative growth rate during the forecast period
• North America held the largest revenue share in 2020 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate

Related Reports@

Point-of-Care Glucose Testing Market

Blood Glucose Monitoring Devices Market

Network Point-of-Care Glucose Testing Market Report Scope

Report Attribute	Details
Market size value in 2021	USD 1.2 billion
Revenue forecast in 2028	USD 1.6 billion
Growth Rate	CAGR of 3.9% from 2021 to 2028
Base year for estimation	2020
Historical data	2016 - 2019
Forecast period	2021 - 2028

 

Network Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global network point-of-care glucose testing market on the basis of product, and region:

Network Point-of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2016 - 2028)

• i-STAT
• Accu-Chek Inform II
• StatStrip
• HemoCue
• CareSens Expert Plus
• BAROzen H Expert Plus

Network Point-of-Care Glucose Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
• • U.S.
  • Canada
• Europe
• • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
• • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
• • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
• • South Africa
  • Saudi Arabia
  • UAE